NDC codes

FDA NDC Directory
Product NDC (as listed)0990-7968Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00990-7968Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0990-7968-090099079680912 BAG in 1 CASE (0990-7968-09) / 1000 mL in 1 BAGMarketed from May 14, 2020

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Normosol-R and Dextrose
Generic name (nonproprietary)
dextrose, sodium chloride, sodium acetate anhydrous, sodium gluconate, potassium chloride, and magnesium chloride
Active ingredients
Dextrose monohydrate — 5 g/100mLSodium chloride — 526 mg/100mLSodium acetate anhydrous — 222 mg/100mLSodium gluconate — 502 mg/100mLPotassium chloride — 37 mg/100mLMagnesium chloride — 30 mg/100mL
Dosage form
Injection, Solution
Route
Intravenous
Labeler
ICU Medical Inc.NDC labeler code 0990
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 017609
Marketing start
Listing expires
Other FDA classes
Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers
Product ID 0990-7968_5a9ea0cc-bc33-45e5-b9ef-8893818e7803SPL ID 5a9ea0cc-bc33-45e5-b9ef-8893818e7803SPL set ID ead1fca3-eff4-478f-8a8f-67510f80151aRxCUI 801024, 1189629UNII LX22YL083G, 451W47IQ8X, NVG71ZZ7P0, R6Q3791S76, 660YQ98I10, 02F3473H9O
Pharmacologic class
Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400990796809 followed by a unit qualifier and the quantity

Package 00990-7968-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Normosol-R and 5% Dextrose Injection is indicated for replacement of acute extracellular fluid volume losses in surgery, trauma, burns or shock. Normosol-R and 5% Dextrose also can be used as an adjunct to restore a decrease in circulatory volume in patients with moderate blood loss. The solution is not intended to supplant transfusion of whole blood or packed red cells in the presence of uncontrolled hemorrhage or severe reductions of red cell volume.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0990-7968

What is NDC 0990-7968?
0990-7968 is the product NDC for Normosol-R and Dextrose, Dextrose monohydrate 5 g/100mL + 5 more ingredients injection, solution, listed with the FDA by ICU Medical Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Normosol-R and Dextrose (Dextrose, Sodium Chloride, Sodium Acetate Anhydrous, Sodium Gluconate, Potassium Chloride, and Magnesium Chloride).
What is the active ingredient?
Dextrose monohydrate, Sodium chloride, Sodium acetate anhydrous, Sodium gluconate, Potassium chloride, Magnesium chloride.
Who is the labeler?
ICU Medical Inc., NDC labeler code 0990. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Normosol-R and Dextrose?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in